You don't need to be signed in to access information on BMJ Masterclasses, but you can register here to receive updates about other BMJ Group products and services via our Group site.

Home > Physician series > Haematology > Haematology Programme 2010

Haematology Programme 2010

0810-0910	REGISTRATION AND REFRESHMENTS
0910-0920	Welcome and introduction by the Chair Dr Drew Provan Senior Lecturer in Haematology, The Royal London Hospital, Queen Mary’s School of Medicine, Whitechapel, London, and Editor, ABC of Clinical Haematology
0920-1005	Myeloproliferative disorders This session will present an update on the management of myeloproliferative disorders. The speaker will cover: How the discovery of JAK2 and other mutations has changed our understanding of polycythaemia vera, essential thrombocythaemia, and idiopathic myelofibrosis How this is already altering the diagnosis, classification, and treatment of these chronic haematological malignancies. Professor Tony Green Head of Haematology, Cambridge Institute for Medical Research, University of Cambridge, Cambridge
1005-1050	Lymphoma This session will outline the major advances that have been made in the management of lymphomas over the past five years, in the development of: Immunochemotherapy Prognostic stratification Response monitoring, particularly with CT and PET scanning. The speaker will highlight how these advances are making individualised treatment a realistic prospect. Dr Robert Marcus Consultant Haematologist, King's College Hospital, London
1050-1110	REFRESHMENTS
1110-1155	Acute leukaemia This session will review the latest understanding of the biology of ALL and AML and outline how this understanding and characterisation of leukaemic cells can help to: Predict disease outcome Provide a framework for risk-stratified treatment including molecularly targeted treatments Track response to anti-leukaemic treatments Develop more tailored individualised treatment. Professor David Grimwade Professor of Molecular Haematology, Department of Medical and Molecular Genetics, King's College London School of Medicine, London
1155-1240	Transfusion medicine Although blood transfusion is an essential part of modern medical and surgical practice, the safety, availability, cost and clinical indications remain controversial. The speaker will give an update on: Risks and benefits of blood component transfusion The developing evidence base to underpin safe and effective clinical practice Transfusion-transmitted vCJD Clinical guidelines Haemovigilance Implementation of Better Blood Transfusion. Dr Derek Norfolk Consultant in Haematology and Transfusion Medicine, NHS Blood & Transplant and Leeds Teaching Hospitals NHS Trust
1240-1340	LUNCH
1340-1425	Industry sponsored symposium More information to follow.
1425-1510	Idiopathic thrombocytopenic purpura In this session, learn more about recent advances in the understanding of ITP, discuss the new drug treatments and hear why overall management has changed in the past few years. Dr Drew Provan Senior Lecturer in Haematology, The Royal London Hospital, Queen Mary’s School of Medicine, Whitechapel, London, and Editor, ABC of Clinical Haematology
1510-1530	REFRESHMENTS
1530-1615	Haematological emergencies The speaker will cover important issues in key haematological emergencies including: Those affecting the immunocompromised patient, such as neutropenic sepsis, pneumococcal septicaemia and hypogammaglobulinaemia Sickle cell crisis and chest syndrome Spinal cord compression Superior vena cava obstruction Hyperviscosity and tumour lysis syndromes Dr Jim Murray Consultant Haematologist, University Hospital Birmingham, Queen Elizabeth Medical Centre, Birmingham
1615-1700	Thrombosis and bleeding This session will help you make decisions based on up to date evidence for: Prevention of venous thrombosis in hospitalised patients Duration of anticoagulation after an episode of venous thrombosis Safe anticoagulant therapy Reversal of anticoagulation Identification of patients with heritable bleeding tendencies and principles of treatment Management of common acquired bleeding disorders. Dr Trevor Baglin Consultant Haematologist, Addenbrooke’s Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge
1700-1710	SUMMARY AND CLOSING REMARKS

PROGRAMME SUBJECT TO CHANGE

ALL CONTENT HAS BEEN REVIEWED BY THE EDITOR

Need help?

Need help or want to register interest or submit an enquiry? Telephone 020 7383 6451.

2010 programmes now open for registration

Useful links

BMJ Learning modules

OnExamination